On the other hand, the presence of infiltrating CD8+ and CD4+ T cells is a favorable prognostic factor in NSCLC, since their activation correlates with a stronger antitumor immune response [72, 73]. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.